DEINOVE signs an Eva
DEINOVE signs an Evaluation and Technology Development License with DSM
19 nov. 2020 12h30 HE | Deinove
DEINOVE signs an Evaluation and Technology Development License with DSM DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that pioneers the application of biodiversity from the...
DEINOVE signe une li
DEINOVE signe une licence d'évaluation et de développement technologique avec DSM
19 nov. 2020 12h30 HE | Deinove
DEINOVE signe une licence d'évaluation et de développement technologique avec DSM DEINOVE (Euronext Growth Paris : ALDEI), société de biotechnologie française pionnière dans l’exploration et...
2020 Half-year resul
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context
01 oct. 2020 12h30 HE | Deinove
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context Clinical program for the antibiotic candidate DNV3837 continues, with the...
Alexis RIDEAU appoin
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Company's strategy for innovation and partnerships
04 mai 2020 01h32 HE | Deinove
Alexis RIDEAU has recognized experience in the development, negotiation and implementation of strategic partnerships in the life sciences field, particularly in microbiology applied to health and...